Home > Archive>Volume 13, Issue 11, 2020 >1808-1813. DOI:10.18240/ijo.2020.11.19
PDF HTML XML Export Cite reminder
Descriptive assessment on diabetic retinopathy screening in an awareness programme in Malaysia
Author:
Corresponding Author:

Nor Asiah Muhamad. Sector for Evidence-Based Healthcare, National Institutes of Health (NIH), Ministry of Health Malaysia, No.1 Setia Murni U13/52 Road, Section U13, Setia Alam City, Shah Alam, Selangor 40170, Malaysia. norasiahdr@gmail.com

  • Article
    • | |
  • Metrics
    • |
  • Reference [35]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    AIM: To determine the prevalence of diabetic retinopathy (DR) among diabetic patients at the primary health clinics in Selangor, Malaysia. METHODS: All diabetic patients were screened in Retinal Disease Awareness Programme (RDAP) and those who had significant DR changes were referred to the hospital for further management. Descriptive analyses were done to determine the prevalence of DR and sociodemographic characteristics among patients with diabetic. Univariate and multivariable analysis using Logistic regression were performed to find association and predictor factors in this screening. RESULTS: A total of 3305 patients aged 40y and above were screened for DR. Of the patients screened, 9% patients were found to have DR and other visual complication such as maculopathy (0.9%), cataract (4.8%) and glaucoma (0.4%). The mean age of patients without retinopathy was 57.82±8.470y and the mean age of patients with DR was 63.93±9.857y. About 61.5% of the patients screened were aged below 60y and 38.5% were aged 60y and above. Majority of the patients screened were women 58.5% and Malay in the age group of 50-59y, while 27% were aged 60-69y. Significant association were found between age, sex, race, visual loss and DR. CONCLUSION: Although the prevalence of DR among patients is not alarming, effective interventions need to be implemented soon to avert a large burden of visual loss from DR.

    Reference
    1 Pandey A, Lamichhane G, Khanal R, Rai SKC, Bhari AM, Borroni D, Gautam N. Assessment of visual morbidity amongst diabetic retinopathy at tertiary eye care center, Nepal: a cross-sectional descriptive study. BMC Ophthalmol 2017;17(1):263.
    2 Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1):4-14.
    3 Thomas RL, Halim S, Gurudas S, Sivaprasad S, Owens DR. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract 2019;157:107840.
    4 Chew FLM, Salowi MA, Mustari Z, Husni MA, Hussein E, Adnan TH, Ngah NF, Limburg H, Goh PP. Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII). PLoS One 2018;13(6):e0198799.
    5 The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981;88(7):583-600.
    6 Skaggs JB, Zhang XX, Olson DJ, Garg S, Davis RM. Screening for diabetic retinopathy: strategies for improving patient follow-up. N C Med J 2017;78(2):121-123.
    7 Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008;15(1):1-4.
    8 Piyasena MMPN, Gudlavalleti VSM, Gilbert C, Yip JL, Peto T, MacLeod D, Fonseka C, Kulatunga A, Bandutilake B, Dhanapala M, Pathirana L, Dissanayake H. Development and validation of a diabetic retinopathy screening modality using a hand-held nonmydriatic digital retinal camera by physician graders at a tertiary-level medical clinic: protocol for a validation study. JMIR Res Protoc 2018;7(12):e10900.
    9 Gehrs KM, Chong LP, Gusman G, et al. Can we educate primary care physicians about diabetic retinopathy after graduation? Preliminary results of the diabetic retinopathy education study. Invest Ophthalmol Vis Sci 1993;34:S1182.
    10 Khandekar R. Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region. Middle East Afr J Ophthalmol 2012;19(2):178-184.
    11 American Academy of Ophthalmology. International Council of Ophthalmology. 2002 October. International Clinical Diabetic Macular Edema Disease Severity Scale. http://www.icoph.org/resources/44/International-Clinical-Diabetic-Macular-Edema-Disease-Severity-Scale-.html
    12 Mallika P, Lee P, Cheah W, Wong J, Syed Alwi S, Nor Hayati H, Tan A. Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in East Malaysia. Malays Fam Physician 2011;6(2-3):60-65.
    13 Krishnadas R, Nirmalan PK, Ramakrishnan R, Thulasiraj RD, Katz J, Tielsch JM, Friedman DS, Robin AL. Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey. Am J Ophthalmol 2003;135(6):830-837.
    14 Thapa SS, Thapa R, Paudyal I, Khanal S, Aujla J, Paudyal G, Rens Gv. Prevalence and pattern of vitreo-retinal diseases in Nepal: the Bhaktapur glaucoma study. BMC Ophthalmol 2013;13:9.
    15 Goh PP, Omar MA, Yusoff AF. Diabetic eye screening in Malaysia: findings from the National Health and Morbidity Survey 2006. Singapore Med J 2010;51(8):631-634.
    16 Viswanath K, McGavin DD. Diabetic retinopathy: clinical findings and management. Community Eye Health 2003;16(46):21-24.
    17 Konstantinidis L, Carron T, de Ancos E, Chinet L, Hagon-Traub I, Zuercher E, Peytremann-Bridevaux I. Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort. BMC Endocr Disord 2017;17(1):56.
    18 Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell P. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008;115(11):1869-1875.
    19 Das BN, Thompson JR, Patel R, Rosenthal AR. The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent. J R Soc Med 1994;87(4):219-222.
    20 Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, Bellary S, Barnett AH, Kumar S, O’Hare JP, UK Asian Diabetes Study Retinopathy Study Group. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 2009;32(3):410-415.
    21 Yau JW, Rogers SL, Kawasaki R, et al, Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-564.
    22 Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46(7):2328-2333.
    23 Piyasena MMPN, Murthy GVS, Yip JLY, Gilbert C, Peto T, Premarathna M, Zuurmond M. A qualitative study on barriers and enablers to uptake of diabetic retinopathy screening by people with diabetes in the Western Province of Sri Lanka. Trop Med Health 2019;47:34.
    24 Song SJ, Han K, Choi KS, Ko SH, Rhee EJ, Park CY, Park JY, Lee KU, Ko KS, Task Force Team for Diabetes Fact Sheet of the Korean Diabetes Association. Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006-2013. J Diabetes Investig 2018;9(1):173-178.
    25 Kollias AN, Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int 2010;107(5):75-83;quiz 84.
    26 Kyari F, Tafida A, Sivasubramaniam S, Murthy GV, Peto T, Gilbert CE, Nigeria National Blindness and Visual Impairment Study Group. Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health 2014;14:1299.
    27 Zheng YF, He MG, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012;60(5):428-431.
    28 Keenum Z, McGwin G Jr, Witherspoon CD, Haller JA, Clark ME, Owsley C. Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded County clinic and factors associated with follow-up eye care use. JAMA Ophthalmol 2016;134(11):1221-1228.
    29 Gibson DM. Diabetic retinopathy and age-related macular degeneration in the US. Am J Prev Med 2012;43(1):48-54.
    30 Ministry of Health. Malaysia. Clinical Practice Guidelines Management of Type 2 Diabetes Mellitus 5th Edition. 2015 December. http://www.moh.gov.my/moh/resources/Penerbitan/CPG/Endocrine/3a.pdf
    31 Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol 2016;44(4):260-277.
    32 Shukla R, Gudlavalleti MV, Bandyopadhyay S, Anchala R, Gudlavalleti AS, Jotheeswaran AT, Ramachandra SS, Singh V, Vashist P, Allagh K, Ballabh HP, Gilbert CE. Perception of care and barriers to treatment in individuals with diabetic retinopathy in India: 11-City 9-state study. Indian J Endocrinol Metab 2016;20(Suppl 1):S33-S41.
    33 Al Zarea BK. Knowledge, attitude and practice of diabetic retinopathy amongst the diabetic patients of AlJouf and hail Province of Saudi Arabia. J Clin Diagn Res 2016;10(5):NC05-NC08.
    34 UK National Screening Committee. Essential elements in developing a diabetic retinopathy screening programme. London: UK National Screening Committee. 2007 Jan.
    35 Arej N, Antoun J, Waked R, Saab C, Saleh M, Waked N. Screening for diabetic retinopathy by non-mydriatic fundus photography: First national campaign in Lebanon. J Fr Ophtalmol 2019;42(3):288-294.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Nor Fariza Ngah, Nor Asiah Muhamad, Zalifa Zakiah Asnir,/et al.Descriptive assessment on diabetic retinopathy screening in an awareness programme in Malaysia. Int J Ophthalmol, 2020,13(11):1808-1813

Copy
Share
Article Metrics
  • Abstract:1284
  • PDF: 674
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:March 06,2020
  • Revised:May 13,2020
  • Online: September 17,2020
You are the 4446817 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.